Earningsreport

Q1/2023 3/31/2023 EPS -0.290 ZacksConsensus -0.330 ActVsEst 0.040 - Beat

Cue Biopharma, Inc.  (CUE) 
US:NASDAQ Investor Relations: cuebiopharma.gcs-web.com/news-releases